Skip to main content
Akero Therapeutics, Inc. (FRA:0K4)
Germany flag Germany · Delayed Price · Currency is EUR
46.58
-0.19 (-0.41%)
Last updated: Dec 5, 2025, 8:02 AM CET

Akero Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
 Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Net Income
-292.82-252.06-151.76-112.03-100.78-79.21
Upgrade
Depreciation & Amortization
0.020.020.030.040.040.02
Upgrade
Other Amortization
0.720.610.790.2--
Upgrade
Asset Writedown & Restructuring Costs
-1----
Upgrade
Loss (Gain) From Sale of Investments
-10.76-13.12-9.55-0.011.070.08
Upgrade
Stock-Based Compensation
34.2829.721.523.2410.056.02
Upgrade
Other Operating Activities
1.540.750.310.50.210.2
Upgrade
Change in Accounts Payable
-4.732.01-0.650.973.272.48
Upgrade
Change in Other Net Operating Assets
21.60.99-6.03-5.436.45-0.4
Upgrade
Operating Cash Flow
-250.17-230.11-145.37-92.52-79.68-70.8
Upgrade
Capital Expenditures
--1----0.15
Upgrade
Investment in Securities
-330.79-108.71-223.62-63.8342.28-9.61
Upgrade
Investing Cash Flow
-330.79-109.71-223.62-63.8342.28-9.76
Upgrade
Long-Term Debt Issued
-101510--
Upgrade
Net Debt Issued (Repaid)
-37.4101510--
Upgrade
Issuance of Common Stock
478.93436.69339.09246.51.12203.96
Upgrade
Other Financing Activities
-0.61-0.84-0.78-0.86-0.52-0.85
Upgrade
Financing Cash Flow
440.93445.85353.32255.630.6203.11
Upgrade
Net Cash Flow
-140.03106.03-15.6799.29-36.8122.54
Upgrade
Free Cash Flow
-250.17-231.11-145.37-92.52-79.68-70.95
Upgrade
Free Cash Flow Per Share
-3.20-3.44-2.77-2.37-2.29-2.25
Upgrade
Cash Interest Paid
4.253.982.480.44--
Upgrade
Levered Free Cash Flow
-156.88-148.48-94.05-53.51-43.22-41.98
Upgrade
Unlevered Free Cash Flow
-154.71-146.17-92.56-53.25-43.22-41.98
Upgrade
Change in Working Capital
16.873-6.67-4.469.732.09
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.